CLSA programs create a platform for accessing the wealth of experience of one of the most vibrant clusters in the world, bringing the life science community together to connect, learn and network. CLSA members receive discounted or complimentary access.
Understanding the drivers of launch excellence in the development stage could be a daunting task for pharmaceutical companies. On March 21, we will discuss how to start your market-shaping activities early and deliver a product that is differentiated in a way that payers, providers and patient value to win the market.
Much of a product’s launch trajectory is determined before launch. To achieve the best possible impact in the first months of launch, you need to be able to manage launch uncertainties by being great in a handful of make-or-break activities. On April 18, we will discuss how to use your final 12 months before launch to develop “must-have” capabilities, position your brand, engage your stakeholders and create competitive advantage to enable a successful launch.
Palo Alto, California
This exciting meeting will include presentations from leaders of major pharmaceutical companies, federal and foundation policy makers, editors from major biomedical publications, and scientists making groundbreaking advances in the drug discovery space.
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
The first six months often set the product trajectory for most pharmaceutical products. On June 13, we will invite several subject matter experts to sit together with you to discuss how excellent launch planning could help you design the six months journey.